secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0001999371-24-006472
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.05, 2.06, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tonix cuts 23 employees, closes Mass. facility; shareholders approve reverse stock split
--------------------------------------------------------------------------------

- Workforce reduction of 23 FTEs and decommissioning of Advanced Development Center in Mass. by June 7, 2024.
- No material charge expected for restructuring; impairment amount not yet determinable.
- Shareholders (61.6% of shares) elected 8 directors, ratified EisnerAmper as auditor.
- Approved reverse stock split of 1:2 to 1:50, board to set exact ratio within one year.
- Approved repricing of up to 93.4M warrants issued Aug-Dec 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937124006472/0001999371-24-006472-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937124006472/tnpx_8k-052224.htm
  HTML page:      https://secwatch.observer/filing/0001999371-24-006472

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer